Docetaxel (D) plus gemcitabine (G) compared with G in elderly patients with advanced non-small cell lung cancer (NSCLC): Preliminary results of a randomized phase III Hellenic Oncology Research Group trial

被引：6
|
作者：
Karampeazis, A.
Vamvakas, L.
Pallis, A. G.
Christophyllakis, C.
Kentepozidis, N. K.
Chandrinos, V.
Polyzos, A.
Athanasiadis, A.
Milaki, G.
Georgoulias, V.
机构：
[1] Hellen Oncol Res Grp, Athens, Greece
[2] Univ Hosp Heraklion, Iraklion, Greece
[3] Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.7605
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7605
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Docetaxel compared with vinorelbine in elderly patients with advanced non-small cell lung cancer (NSCLC): A randomized phase II Hellenic Oncology Research Group trial
    Karampeazis, A.
    Vamvakas, L.
    Agelidou, A.
    Chandrinos, V.
    Tsiafaki, X.
    Christophylakis, C.
    Chainis, K.
    Kakolyris, S.
    Kalykaki, A.
    Mavroudis, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Preliminary results of a phase II trial of Docetaxel (D) and Gemcitabine (G) in advanced Non-Small Cell Lung Cancer (NSCLC) in elderly and/or unfit patients (PTS)
    Buffoni, Lucio
    Grillo, Raffaella
    Barone, Carla
    Dongiovanni, Diego
    Gaspari, Fabio
    Giacobino, Alice
    Consito, Lorena
    Ciuffreda, Libero
    Schena, Marina
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S668 - S668
  • [3] Pemetrexed (MTA) compared with erlotinib (ERL) in pretreated patients with advanced non-small cell lung cancer (NSCLC): Results of a randomized phase III Hellenic Oncology Research Group trial
    Vamvakas, L.
    Agelaki, S.
    Kentepozidis, N. K.
    Karampeazis, A.
    Pallis, A. G.
    Christophyllakis, C.
    Kotsakis, A. P.
    Boukovinas, I.
    Mavroudis, D.
    Georgoulias, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Docetaxel plus gemcitabine versus gemcitabine in elderly patients with advanced non-small cell lung cancer and use of a geriatric assessment: Lessons from a prematurely closed Hellenic Oncology Research Group randomized phase III study
    Karampeazis, Athanasios
    Vamvakas, Lambros
    Kotsakis, Athanasios
    Christophyllakis, Charalambos
    Kentepozidis, Nikolaos
    Chandrinos, Vassilios
    Agelidou, Anna
    Polyzos, Aris
    Tsiafaki, Xanthi
    Hatzidaki, Dora
    Georgoulias, Vassilis
    JOURNAL OF GERIATRIC ONCOLOGY, 2017, 8 (01) : 23 - 30
  • [5] Docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer (NSCLC): a preliminary report of a randomized phase III trial
    Karampeazis, A.
    Vamvakas, L.
    Tsiafaki, X.
    Kalykaki, A.
    Christophyllakis, Ch.
    Bozionelou, V.
    Gkioulbasanis, J.
    Markos, V.
    Giannousi, Z.
    Androulakis, N.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 64 : S41 - S42
  • [6] Preliminary results of G>GVIELC:: A phase III trial of gemcitabine associated to vindesine or gemcitabine alone in elderly or poor performance patients with advanced non-small cell lung cancer (NSCLC)
    Santo, A.
    Genestreti, G.
    Azzoni, P.
    Palmeri, S.
    Caffo, O.
    Cipriani, A.
    Binato, E.
    Cartei, G.
    Portalone, L.
    Sava, T.
    Molino, A. M.
    Cetto, G. L.
    ANNALS OF ONCOLOGY, 2006, 17 : XI20 - XI20
  • [7] Oral vinorelbine and gemcitabine (oVG) versus docetaxel and gemcitabine (DG) as first-line treatment of patients with advanced non-small cell lung cancer (NSCLC): a subgroup analysis for elderly patients of a phase III randomized trial from the Hellenic Oncology Research Group (HORG)
    Vamvakas, L.
    Karampeazis, A.
    Agelaki, S.
    Agelidou, A.
    Kotsakis, A.
    Kakolyris, S.
    Polyzos, A.
    Pallis, A.
    Saloustros, E.
    Georgoulias, V.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 64 : S49 - S49
  • [8] Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small cell lung cancer: A phase III randomized trial
    Georgoulias, V.
    Ardavanis, A.
    Tsiafaki, X.
    Agelidou, A.
    Syrigos, K.
    Polyzos, A.
    Kakolyris, S.
    Kouroussis, Ch
    Androulakis, N.
    Chatzidaki, D.
    ANNALS OF ONCOLOGY, 2004, 15 : 169 - 169
  • [9] Docetaxel Vs. Vinorelbine in Elderly Patients With Advanced Non-Small-Cell Lung Cancer: A Hellenic Oncology Research Group Randomized Phase III Study
    Karampeazis, Athanasios
    Vamvakas, Lambros
    Agelidou, Athina
    Kentepozidis, Nikolaos
    Chainis, Kyriakos
    Chandrinos, Vassilis
    Vardakis, Nikolaos
    Pallis, Athanasios G.
    Christophyllakis, Charalambos
    Georgoulias, Vassilis
    CLINICAL LUNG CANCER, 2011, 12 (03) : 155 - 160
  • [10] DOCETAXEL (D) VERSUS DOCETAXEL/GEMCITABINE (D&G) IN THE TREATMENT OF OLDER PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): AN ALPE ADRIA THORACIC ONCOLOGY MULTIDISCIPLINARY GROUP RANDOMIZED PHASE II TRIAL (ATOM 017)
    Rijavec, E.
    Belvedere, O.
    Aita, M.
    Rossetto, C.
    Follador, A.
    Sacco, C.
    Ceschia, T.
    Genova, C.
    Fasola, G.
    Grossi, F.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S87 - S87
12345